Please use this identifier to cite or link to this item: https://hdl.handle.net/11000/30744
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPérez-Sempere, Ángel-
dc.contributor.authorFeliu-Rey, Eloisa-
dc.contributor.authorSánchez-Pérez, Rosa-
dc.contributor.authorNieto-Navarro, Juan-
dc.contributor.otherDepartamentos de la UMH::Medicina Clínicaes_ES
dc.date.accessioned2024-01-26T10:59:51Z-
dc.date.available2024-01-26T10:59:51Z-
dc.date.created2013-06-26-
dc.identifier.citationJournal of neurology, neurosurgery and psychiatry, June 2013es_ES
dc.identifier.issn1468-330X-
dc.identifier.issn0022-3050-
dc.identifier.urihttps://hdl.handle.net/11000/30744-
dc.formatapplication/pdfes_ES
dc.format.extent4es_ES
dc.language.isoenges_ES
dc.publisherBMJ Journalses_ES
dc.rightsinfo:eu-repo/semantics/closedAccesses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleRituximab for tumefactive demyelination refractory to corticosteroids and plasma exchangees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttps://doi.org/10.1136/jnnp-2013-305456es_ES
Appears in Collections:
Artículos Medicina Clínica


no-thumbnailView/Open:

 Rituximab for tumefactive demyelination refractory.pdf



165,59 kB
Adobe PDF
Share:


Creative Commons ???jsp.display-item.text9???